Sign inJoin waitlistJoin the waitlist

Jonathan Yang

Associate Professor and Vice Chair of Research, Department of Radiation Oncology at NYU Grossman School of Medicine · NYU Grossman School of Medicine

Credentials: · · · · · ·

History

Department of Radiation Oncology at NYU Grossman School of Medicine
Present
Brain and Spine Tumor Center · NYU Grossman School of Medicine
Present
Research · NYU Grossman School of Medicine
Present

Radiation Oncology
Memorial Sloan Kettering Cancer Center
2012–2016
Preliminary or Transitional Year
2011–2012
Yale School of Medicine
2007–2011

Research

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
JAMA Oncology · 2017 · 549 citations
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
Journal of Clinical Oncology · 2017 · 386 citations
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of…
The Lancet · 2024 · 251 citations

Yoshiya Yamada
26 papers
Erin Gillespie
20 papers
KB
Kathryn Beal
17 papers
RY
Robert Young
17 papers
CT
Chiaojung Tsai
15 papers
Daniel Gomez
14 papers
DY
Divya Yerramilli
13 papers · 2 as a resident
Neil Wijetunga
13 papers · 10 as a resident
Simon Powell
12 papers
Adrienne Boire
11 papers
AL
Andrew Lin
11 papers
VT
Viviane Tabar
11 papers

Clinical trials

Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases
Principal investigator · Not yet recruiting · Phase 1
NYU Langone Health
2026–2031
Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac
Principal investigator · Not yet recruiting · Phase 1
NYU Langone Health
2026–2029
Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
Principal investigator · Recruiting · Early phase 1
NYU Langone Health
2025–2031
Concurrent Azeliragon With Craniospinal Irradiation
Principal investigator · Active not recruiting · Phase 1
NYU Langone Health
2025–2031